Fabrizio Micheli

1.8k citations

68 papers · 1.2k indexed · h-index 21

Molecular Biology
Organic Chemistry top 5%
Cellular and Molecular Neuroscience top 5%
Spectroscopy top 10%
Pharmacology

Co-authors: Christian Heidbreder Daniele Donati Anna Bernardi Romano Di Fabio Pierfausto Seneci Giovanna Tedesco Donatella Potenza Silvia Terreni
Topics: Neuroscience and Neuropharmacology Research (25 papers)Receptor Mechanisms and Signaling (21 papers)Chemical Synthesis and Analysis (16 papers)
Cited by: Cellular and Molecular Neuroscience Organic Chemistry Molecular Biology
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Neuropsychopharmacology
Partner nations: Italy United Kingdom United States

In The Last Decade

Fabrizio Micheli

64 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fabrizio Micheli

Since Specialization

Citations

This map shows the geographic impact of Fabrizio Micheli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Micheli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Micheli more than expected).

Fields of papers citing papers by Fabrizio Micheli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Micheli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Micheli. The network helps show where Fabrizio Micheli may publish in the future.

Co-authorship network of co-authors of Fabrizio Micheli

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Micheli. A scholar is included among the top collaborators of Fabrizio Micheli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Micheli. Fabrizio Micheli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry ·Fabrizio Micheli,(unknown),Federica Bianchi,Simone Braggio,Laura Castelletti,(unknown),Paolo Cavanni,(unknown),(unknown),Aldo Feriani,Beatrice Oliosi,(unknown),Luca Tarsi,Silvia Tomelleri,(unknown),(unknown),Laura Zonzini,Christian Heidbreder	17
2	Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,(unknown),(unknown),Luca Tarsi,Silvia Tomelleri,Paolo Cavanni,Beatrice Oliosi,(unknown),Anna Sava,Laura Zonzini,Aldo Feriani,Simone Braggio,Christian Heidbreder	19
3	Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach 2012 ·Neuropsychopharmacology ·Manolo Mugnaini,Laura Iavarone,(unknown),Cristiana Griffante,Beatrice Oliosi,(unknown),John D. Beaver,Eugenii A. Rabiner,Fabrizio Micheli,Christian Heidbreder,Anne C. Andorn,Emilio Merlo Pich,Massimo Bani	68
4	1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Fabrizio Micheli,Paolo Cavanni,Michela Bettati,Giorgio Bonanomi,Romano Di Fabio,(unknown),Carla Marchioro,(unknown),Luca Tarsi,(unknown),Laura Zonzini,Angela Worby	4
5	Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Roberto Arban,Federica Bianchi,Alberto Buson,(unknown),Romano Di Fabio,Gabriella Gentile,Fabrizio Micheli,(unknown),Alfonso Pozzan,Luca Tarsi,Silvia Terreni,(unknown)	34
6	Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D₃ Receptor Antagonists 2010 ·ChemMedChem ·Giorgio Bonanomi,Simone Braggio,Anna Maria Capelli,Anna Checchia,(unknown),Carla Marchioro,Luca Tarsi,Giovanna Tedesco,Silvia Terreni,Angela Worby,(unknown),Fabrizio Micheli	16
7	Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ian P. Holmes,Fabrizio Micheli,(unknown),Olivier Lorthioir,Steve P. Watson,Romano Di Fabio,Gabriella Gentile,Christian Heidbreder,(unknown),Angela Worby	9
8	Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies 2009 ·Bioorganic & Medicinal Chemistry Letters ·Idriss Bennacef,Cristian Salinas,Thomas A. Bonasera,Roger N. Gunn,Hélène Audrain,Steen Jakobsen,Nabeel Nabulsi,David Weinzimmer,Richard E. Carson,Yiyun Huang,Ian P. Holmes,Fabrizio Micheli,Christian Heidbreder,(unknown),Tino Rossi,Marc Laruelle	19
9	Phenylethynyl-pyrrolo[1,2-a]pyrazine: A new potent and selective tool in the mGluR5 antagonists arena 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Barbara Bertani,(unknown),Luca Crippa,Paolo Cavanni,Romano Di Fabio,Daniele Donati,(unknown),(unknown),Alfredo Paio,(unknown),Paola Zarantonello	27
10	New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Giorgio Bonanomi,Simone Braggio,Anna Maria Capelli,(unknown),(unknown),Romano Di Fabio,Daniele Donati,Stefania Gagliardi,Gabriella Gentile,Dieter Hamprecht,Marcella Petrone,Stefano Radaelli,Giovanna Tedesco,Silvia Terreni,Angela Worby,Christian Heidbreder	21
11	From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: A new class of orally bioavailable mGluR1 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio,Fabrizio Micheli,Giuseppe Alvaro,Paolo Cavanni,Daniele Donati,(unknown),Gabriele Fontana,Riccardo Giovannini,(unknown),(unknown),(unknown),Giovanni Vitulli	26
12	Isoindolone derivatives, a new class of 5-HT2C antagonists: Synthesis and biological evaluation 2006 ·Bioorganic & Medicinal Chemistry Letters ·Dieter Hamprecht,Fabrizio Micheli,Giovanna Tedesco,Anna Checchia,Daniele Donati,Marcella Petrone,Silvia Terreni,Martyn Wood	44
13	5-HT2C antagonists based on fused heterotricyclic templates: Design, synthesis and biological evaluation 2006 ·Bioorganic & Medicinal Chemistry Letters ·Dieter Hamprecht,Fabrizio Micheli,Giovanna Tedesco,Daniele Donati,Marcella Petrone,Silvia Terreni,Martyn Wood	12
14	From pyrroles to pyrrolo[1,2-a]pyrazinones: A new class of mGluR1 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Paolo Cavanni,Romano Di Fabio,Carla Marchioro,Daniele Donati,(unknown),(unknown),Fabio Maria Sabbatini,(unknown)	10
15	Stereoselective synthesis and preliminary evaluation of (+)- and (–)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist 2004 ·Il Farmaco ·Gabriele Costantino,Maura Marinozzi,Emidio Camaioni,Benedetto Natalini,(unknown),Fabrizio Micheli,Paolo Cavanni,(unknown),Christian R. Noe,Flavio Moroni,Roberto Pellicciari	9
16	3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I 2004 ·Il Farmaco ·Fabrizio Micheli,Romano Di Fabio,(unknown),Anna Maria Capelli,(unknown),Paolo Cavanni,(unknown),Daniele Donati,Aldo Feriani,(unknown),Mahmoud Hamdan,(unknown),Fabio Maria Sabbatini,(unknown),(unknown)	17
17	Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor 2003 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio,(unknown),Barbara Bertani,Giuseppe Alvaro,Fabrizio Micheli,Fabio Maria Sabbatini,(unknown),(unknown),(unknown),(unknown),Daniele Donati,Emiliangelo Ratti,Roberto Arban,(unknown),Angelo Reggiani,Robert J. Barnaby	20
18	2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold 2003 ·Il Farmaco ·Fabrizio Micheli,Romano Di Fabio,Paolo Cavanni,Daniele Donati,(unknown),(unknown),(unknown),Carla Marchioro,Fabio Maria Sabbatini,Giorgio Tarzia,(unknown),(unknown)	5
19	A new alternative synthesis of 5-cyanophthalide, a versatile intermediate in the preparation of the antidepressant drug citalopram 2001 ·Il Farmaco ·Fabrizio Micheli,Luca Crippa,Daniele Donati,Romano Di Fabio,Colin P. Leslie	1
20	New Synthesis of Substituted 2-Carboxyindole Derivatives: Versatile Introduction of a Carbamoylethynyl Moiety at the C-3 Position 1999 ·Archiv der Pharmazie ·(unknown),Romano Di Fabio,(unknown),(unknown),(unknown),Fabrizio Micheli,(unknown)	11

About Fabrizio Micheli

Fabrizio Micheli is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Organic Chemistry, having authored 68 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (25 papers), Receptor Mechanisms and Signaling (21 papers) and Chemical Synthesis and Analysis (16 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (423 citations), Organic Chemistry (582 citations) and Molecular Biology (645 citations). Fabrizio Micheli has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Christian Heidbreder, Daniele Donati, Anna Bernardi, Romano Di Fabio, Pierfausto Seneci, Giovanna Tedesco, Donatella Potenza, Silvia Terreni, Aldo Feriani and Fabio Maria Sabbatini. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact